228 related articles for article (PubMed ID: 19491278)
1. Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types.
Fujita T; Teramoto K; Ozaki Y; Hanaoka J; Tezuka N; Itoh Y; Asai T; Fujino S; Kontani K; Ogasawara K
Cancer Res; 2009 Jun; 69(12):5142-50. PubMed ID: 19491278
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous elicitation of potent antitumor immunity and eradication of established tumors by administration of DNA encoding soluble transforming growth factor-beta II receptor without active antigen-sensitization.
Kontani K; Kajino K; Huangi CL; Fujino S; Taguchi O; Yamauchi A; Yokomise H; Ogasawara K
Cancer Immunol Immunother; 2006 May; 55(5):579-87. PubMed ID: 16032398
[TBL] [Abstract][Full Text] [Related]
3. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines.
Kobie JJ; Wu RS; Kurt RA; Lou S; Adelman MK; Whitesell LJ; Ramanathapuram LV; Arteaga CL; Akporiaye ET
Cancer Res; 2003 Apr; 63(8):1860-4. PubMed ID: 12702574
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
Won J; Kim H; Park EJ; Hong Y; Kim SJ; Yun Y
Cancer Res; 1999 Mar; 59(6):1273-7. PubMed ID: 10096559
[TBL] [Abstract][Full Text] [Related]
7. Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum.
Tanaka K; Matsui Y; Ishikawa S; Kawanishi T; Harada M
Oncol Rep; 2012 Feb; 27(2):325-32. PubMed ID: 22086364
[TBL] [Abstract][Full Text] [Related]
8. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
Koehler H; Kofler D; Hombach A; Abken H
Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
[TBL] [Abstract][Full Text] [Related]
9. Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs.
Zhang Y; Wakita D; Chamoto K; Narita Y; Matsubara N; Kitamura H; Nishimura T
Int Immunol; 2007 Feb; 19(2):151-61. PubMed ID: 17189593
[TBL] [Abstract][Full Text] [Related]
10. Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses.
Xie Y; Bai O; Yuan J; Chibbar R; Slattery K; Wei Y; Deng Y; Xiang J
Cancer Res; 2009 Oct; 69(19):7756-66. PubMed ID: 19789353
[TBL] [Abstract][Full Text] [Related]
11. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.
Gorelik L; Flavell RA
Nat Med; 2001 Oct; 7(10):1118-22. PubMed ID: 11590434
[TBL] [Abstract][Full Text] [Related]
13. The involvement of transforming growth factor beta in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT).
Harada M; Matsunaga K; Oguchi Y; Iijima H; Ito O; Tamada K; Kimura G; Nomoto K
Cancer Res; 1995 Dec; 55(24):6146-51. PubMed ID: 8521406
[TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression.
Huber D; Philipp J; Fontana A
J Immunol; 1992 Jan; 148(1):277-84. PubMed ID: 1727872
[TBL] [Abstract][Full Text] [Related]
15. Potent immunosuppression by a bivalent molecule binding to CD200R and TGF-betaR.
Gorczynski RM; Chen Z; Shivagnahnam S; Taseva A; Wong K; Yu K; Khatri I
Transplantation; 2010 Jul; 90(2):150-9. PubMed ID: 20548263
[TBL] [Abstract][Full Text] [Related]
16. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
Wrzesinski SH; Wan YY; Flavell RA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer.
Tzai TS; Lin CI; Shiau AL; Wu CL
Anticancer Res; 1998; 18(3A):1585-9. PubMed ID: 9673374
[TBL] [Abstract][Full Text] [Related]
19. A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats.
Yamamoto Y; Ueda Y; Itoh T; Iwamoto A; Yamagishi H; Shimagaki M; Teramoto K
Oncol Rep; 2006 Dec; 16(6):1277-84. PubMed ID: 17089050
[TBL] [Abstract][Full Text] [Related]
20. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C
Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
